Side-by-side comparison of AI visibility scores, market position, and capabilities
T. Rowe Price (TROW) reported ~$7.1B revenue in FY2024. Leading independent asset manager with $1.6T in AUM, known for actively managed mutual funds for retirement investors. HQ: Baltimore.
T. Rowe Price Group, Inc. is one of the largest independent investment management companies in the United States, managing approximately $1.6 trillion in assets under management (AUM) across actively managed equity, fixed income, and multi-asset strategies. Founded in Baltimore in 1937 by Thomas Rowe Price Jr. — the father of growth investing — the company has maintained an independent ownership structure (not part of a bank or insurance company) and a culture of proprietary investment research that distinguishes it from increasingly passive competitors.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.